Oppenheimer Asset Management Inc. Exelixis, Inc. Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$14.96 - $17.39 $118,647 - $137,920	-7,931 Reduced 22.23%	27,749 $445,000
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $165,721 - $235,371	-10,569 Reduced 22.85%	35,680 $559,000
Q2 2022 Aug 08, 2022	SELL	$17.44 - $23.16 $30,363 - $40,321	-1,741 Reduced 3.63%	46,249 $963,000
Q1 2022 May 12, 2022	BUY	$17.03 - $22.67 $67,217 - $89,478	3,947 Added 8.96%	47,990 $1.09 Million
Q4 2021 Feb 02, 2022	BUY	$15.84 - $21.88 $53,618 - $74,063	3,385 Added 8.33%	44,043 $805,000
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $32,795 - $42,533	-2,012 Reduced 4.72%	40,658 $859,000
Q2 2021 Aug 03, 2021	BUY	$17.95 - $25.56 $18,237 - $25,968	1,016 Added 2.44%	42,670 $777,000
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $26,381 - $32,407	-1,285 Reduced 2.99%	41,654 $941,000
Q4 2020 Feb 11, 2021	SELL	$18.39 - $24.8 $52,760 - $71,151	-2,869 Reduced 6.26%	42,939 $862,000
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $31,025 - $40,436	-1,501 Reduced 3.17%	45,808 $1.12 Million
Q2 2020 Aug 11, 2020	SELL	$16.46 - $27.42 $126,742 - $211,134	-7,700 Reduced 14.0%	47,309 $1.12 Million
Q1 2020 May 08, 2020	BUY	$14.46 - $21.8 $21,993 - $33,157	1,521 Added 2.84%	55,009 $947,000
Q4 2019 Feb 07, 2020	BUY	$15.15 - $18.89 $12,120 - $15,112	800 Added 1.52%	53,488 $943,000
Q3 2019 Oct 31, 2019	SELL	$17.68 - $22.65 $48,832 - $62,559	-2,762 Reduced 4.98%	52,688 $932,000
Q2 2019 Aug 09, 2019	BUY	$18.93 - $24.75 $156,626 - $204,781	8,274 Added 17.54%	55,450 $1.19 Million
Q1 2019 Apr 24, 2019	SELL	$19.6 - $24.76 $93,648 - $118,303	-4,778 Reduced 9.2%	47,176 $1.12 Million
Q4 2018 Jan 30, 2019	BUY	$13.65 - $21.8 $709,172 - $1.13 Million	51,954 New	51,954 $1.02 Million
Q3 2018 Oct 26, 2018	SELL	$15.87 - $22.4 $160,366 - $226,352	-10,105 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$18.56 - $22.45 $187,548 - $226,857	10,105 New	10,105 $217,000
Q4 2017 Feb 07, 2018	SELL	$24.23 - $30.93 $53,281 - $68,015	-2,199 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $51,346 - $64,298	2,199	2,199 $53,000

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account